ABOUT CHEYANNE MALLAS

Cheyanne Mallas is the Founder and CEO of The Private Suite LA and the creator of Precision Longevity™, a biomarker-driven health intelligence optimization platform that helps clinicians translate complex laboratory data into personalized longevity insights and actionable care pathways.

 

Drawing on an extensive background in regenerative aesthetics, longevity science, and preventive health, Cheyanne recognized that while clinicians have access to an unprecedented amount of laboratory and biomarker data, many lack a standardized, evidence-informed framework for transforming that information into personalized longevity strategies. Precision Longevity™ was created to bridge that gap by converting complex health data into clear, individualized insights that support proactive, precision-based care.

 

What began as a clinical framework has evolved into a scalable technology platform designed for longevity clinics, concierge medicine, integrative medicine, and other forward-thinking healthcare organizations. The platform integrates biomarker analysis, health scoring, and personalized optimization pathways into a comprehensive framework that supports more individualized, data-informed care.

 

The Private Suite LA serves as the foundation for Cheyanne’s vision of bringing together regenerative aesthetics, longevity science, and technology to advance a more personalized approach to healthy aging. Her work has focused on regenerative strategies, biomarker-driven optimization, and evidence-based approaches that support long-term health and wellness.

 

Ivy League–trained, with a Master of Health Sciences degree from Weill Cornell Medical College, Cheyanne has built her career at the intersection of regenerative medicine, longevity science, and aesthetic innovation. She is recognized for translating complex scientific concepts into practical frameworks that advance a more proactive and personalized approach to health optimization.

 

Her work has been featured in leading publications, including Forbes, and she continues to educate clinicians, healthcare professionals, and consumers on regenerative aesthetics, longevity science, biomarker optimization, and evidence-based healthy aging.

 

Today, Cheyanne’s vision extends beyond aesthetics. Through Precision Longevity™, she is building a platform designed to help redefine how healthcare providers interpret biomarker data, personalize care, and support healthier aging through science, technology, and innovation.